{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:03:55Z","timestamp":1785859435395,"version":"3.56.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.inf.0000188196.87969.9a","type":"journal-article","created":{"date-parts":[[2005,12,23]],"date-time":"2005-12-23T04:01:44Z","timestamp":1135310504000},"page":"S189-S197","source":"Crossref","is-referenced-by-count":34,"title":["Respiratory Syncytial Virus Infections: Old Challenges and New Opportunities"],"prefix":"10.1097","volume":"24","author":[{"given":"Asunci\u00f3n","family":"Mej\u00edas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ch\u00e1vez-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan S.","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00019053-200422050-00001","article-title":"Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases.","volume":"22","author":"Paramore","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults.","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"R3-7-20210202","first-page":"1159","article-title":"Respiratory syncytial virus activity: United States, 2003\u20132004.","volume":"53","year":"2004","journal-title":"MMWR"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1542\/neo.6-1-e26","article-title":"Respiratory syncytial virus prophylaxis.","volume":"6","author":"Mejias","year":"2005","journal-title":"Neoreviews"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1086\/386372","article-title":"Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.","volume":"189","author":"Jafri","year":"2004","journal-title":"J Infect Dis"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.48.5.1811-1822.2004","article-title":"Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.","volume":"48","author":"Mejias","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1695-4033(04)78805-0","article-title":"Asthma and respiratory syncytial virus: new opportunities for therapeutic intervention.","volume":"61","author":"Mejias","year":"2004","journal-title":"An Pediatr (Barc)"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants.","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/423213","article-title":"Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis\u00ae)-resistant mutants.","volume":"190","author":"DeVincenzo","year":"2004","journal-title":"J Infect Dis"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jmb.2005.04.049","article-title":"Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.","volume":"350","author":"Wu","year":"2005","journal-title":"J Mol Biol"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2003.10.005","article-title":"Antigen presentation by a macrophage-like cell line persistently infected with respiratory syncytial virus.","volume":"99","author":"Guerrero-Plata","year":"2004","journal-title":"Virus Res"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.200308-1203OC","article-title":"Latency and persistence of respiratory syncytial virus despite T cell immunity.","volume":"169","author":"Schwarze","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1743-422X-2-46","article-title":"Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.","volume":"2","author":"Chavez-Bueno","year":"2005","journal-title":"Virol J"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1164\/rccm.2401013","article-title":"The brume surrounding respiratory syncytial virus persistence.","volume":"169","author":"Tripp","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1086\/427998","article-title":"In search of a vaccine for respiratory syncytial virus: the saga continues.","volume":"191","author":"Englund","year":"2005","journal-title":"J Infect Dis"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"11198","DOI":"10.1128\/JVI.78.20.11198-11207.2004","article-title":"Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys.","volume":"78","author":"Tang","year":"2004","journal-title":"J Virol"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.","volume":"191","author":"Karron","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000637-200604000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:11:07Z","timestamp":1785856267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200511001-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000188196.87969.9a","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}